LAF389

CAS No. 270902-51-7

LAF389( LAF-389 | LAF 389 )

Catalog No. M13827 CAS No. 270902-51-7

LAF389 is a potent methionine aminopeptidase (MetAP) inhibitor with IC50 of 800 nM for MetAP-2.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
100MG Get Quote Get Quote
200MG Get Quote Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    LAF389
  • Note
    Research use only, not for human use.
  • Brief Description
    LAF389 is a potent methionine aminopeptidase (MetAP) inhibitor with IC50 of 800 nM for MetAP-2.
  • Description
    LAF389 is a potent methionine aminopeptidase (MetAP) inhibitor with IC50 of 800 nM for MetAP-2, inhibits both MetAp1 and 2, potently inhibits HUVEC proliferation with IC50 of 20 nM; demonstrates both antiproliferative and antiangiogenetic properties, and preclinical investigations showed a broad antitumour activity.Blood CancerPhase 1 Discontinued.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    LAF-389 | LAF 389
  • Pathway
    Metabolic Enzyme/Protease
  • Target
    Aminopeptidase
  • Recptor
    Aminopeptidase
  • Research Area
    Cancer
  • Indication
    Blood cancer

Chemical Information

  • CAS Number
    270902-51-7
  • Formula Weight
    498.617
  • Molecular Formula
    C25H42N2O8
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    CC(C)(C)C=CC(C(C(C(C(=O)NC1CCC(CNC1=O)OC(=O)C2CCCCC2)OC)O)O)O
  • Chemical Name
    [(3R,6S)-7-oxo-6-[[(E,2R,3R,4S,5R)-3,4,5-trihydroxy-2-methoxy-8,8-dimethylnon-6-enoyl]amino]azepan-3-yl] cyclohexanecarboxylate

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Kinder FR Jr, et al. J Med Chem. 2001 Oct 25;44(22):3692-9. 2. Towbin H, et al. J Biol Chem. 2003 Dec 26;278(52):52964-71. 3. Kim S, et al. Cancer Res. 2004 May 1;64(9):2984-7. 4. Dumez H, et al. Anticancer Drugs. 2007 Feb;18(2):219-25.
molnova catalog
related products
  • JNJ-26993135

    JNJ-26993135 is a potent, selective leukotriene A4 hydrolase (LTA4H) inhibitor.

  • TNP-470

    TNP-470 (AGM-1470) is a specific, rreversible MetAP-2 inhibitor and and annti-angiogenic compound.

  • Tosedostat

    Tosedostat (CHR-2797, CHR2797) is a potent, orally bioavailable aminopeptidases inhibitor.